Clinical Trial Update: Flaxseed Intervention on Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A flaxseed intervention trial for metabolic syndrome has completed Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Metabolic Syndrome X | Phase 2, Phase 3 | Status: COMPLETED